Search Immortality Topics:



Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy

Posted: October 27, 2022 at 1:55 am

Ad hoc announcement pursuant to Art. 53 LR

Originally posted here:
Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy

Recommendation and review posted by Fredricko